In a report released today, Jeff Jones from Oppenheimer reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price target of ...

A live webcast will be available on the Alumis website in the "Investors" section under the “Events” page. About Alumis Alumis is a clinical-stage biopharmaceutical company developing oral therapies ...

Peter Oppenheimer, Goldman Sachs chief global equity strategist and head of macro research, joins 'Squawk Box' to discuss the latest market trends, why he believes that markets are vulnerable to a ...

Regal Rexnord (NYSE:RRX – Free Report) had its price objective reduced by Oppenheimer from $210.00 to $190.00 in a research note issued to investors on Friday,Benzinga reports. Oppenheimer currently ...

Roth Capital increased their FY2025 EPS estimates for EnerSys in a research note issued to investors on Friday, February 7th. Roth Capital analyst C. Moore now expects that the industrial products ...

Christopher Nolan's next film will adapt Homer's epic poem 'The Odyssey,' and the cast is stacked for the feature film with a summer 2026 release date ...

Oppenheimer analysts downgraded Pliant Therapeutics stock from Outperform to Perform, following a significant development ...

Heather Perry made a bold bet before last year's holiday rush: switch all e-commerce operations of her family-owned roastery, ...

Miles Teller (“Whiplash, “Top Gun: Maverick”) and Casey Affleck (“Manchester By the Sea,” “Oppenheimer”) are set to lead the cast of pursuit thriller “Wild Game.” “Wild Game” comes from ...

The company's press release indicated that the enrollment and dosing for the BEACON-IPF trial were voluntarily paused to review data and understand the DSMB's recommendation. While the study remains ...